AOTI (LSE:AOTI) ROC %: 18.21% (As of Dec. 2025)


LSE:AOTI AOTI Inc LSE:AOTI
21 GF Score
Price £0.62
! 8 Warning Signs
View Full Analysis

What is AOTI ROC %?

AOTI LSE:AOTI 21 ROC % is 18.21% as of Dec. 2025. GuruFocus rates LSE:AOTI with a GF Score™ of 21/100. The stock has 8 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. AOTI's annualized return on capital (ROC %) for the quarter that ended in Dec. 2025 was 18.21%.

As of today (2026-07-01), AOTI's WACC % is 10.61%. AOTI's ROC % is 13.35% (calculated using TTM income statement data). AOTI generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


AOTI  (LSE:AOTI) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, AOTI's WACC % is 10.61%. AOTI's ROC % is 13.35% (calculated using TTM income statement data). AOTI generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


AOTI ROC % Related Terms


AOTI ROC % Historical Data

* Premium members only.

The historical data trend for AOTI's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AOTI ROC % Chart

AOTI Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROC %
46.54 -1.63 -28.95 5.23 13.58

AOTI Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROC % Get a 7-Day Free Trial -44.00 -26.29 24.07 3.64 18.21
LSE:AOTI
21GF Score
AOTI Inc LSE:AOTI
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AOTI ROC % Calculation

AOTI's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=4.129 * ( 1 - 12.52% )/( (22.596 + 30.586)/ 2 )
=3.6120492/26.591
=13.58 %

where

AOTI's annualized Return on Capital (ROC %) for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=5.314 * ( 1 - 0% )/( (27.763 + 30.586)/ 2 )
=5.314/29.1745
=18.21 %

where

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of 18.21% mean?
AOTI (LSE:AOTI) has a ROC % of 18.21% as of Dec. 2025. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on AOTI and its competitors.
Is AOTI's ROC % too high?
AOTI's current ROC % is 18.21%. The Medical Devices & Instruments industry median ROC % is 1.25. AOTI's value of 18.21% is 1356.8% above this industry median. Overall, AOTI has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does AOTI's ROC % compare to ABT and SYK?
AOTI's ROC % of 18.21% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROC % is 1.25. AOTI's value of 18.21% is 1356.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Medical Devices & Instruments company?
The median ROC % among Medical Devices & Instruments companies is 1.25, based on 847 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AOTI's current ROC % of 18.21% is 1356.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on AOTI and its competitors. For the Medical Devices & Instruments industry, the median ROC % is 1.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AOTI's current ROC % is 18.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AOTI stock overvalued right now?
AOTI (LSE:AOTI) has a current ROC % of 18.21%. The current ROC % is 18.21% and 1356.8% above the Medical Devices & Instruments industry median of 1.25. AOTI's overall GF Score™ is 21/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For AOTI (LSE:AOTI), the current ROC % is 18.21% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AOTI Business Description

Address 3512 Seagate Way, Suite 100, Oceanside, CA, USA, 92056
AOTI Inc is the design, manufacture and provision of topical oxygen therapy products and services for healthcare providers and patients with chronic wounds. These products and services enable patients to heal faster and more durably and healthcare providers to reduce the overall cost of care. The specific purposes of the Company are to patent, manufacture, rent, and sell medical devices to help resolve severe acute and chronic wounds for customers globally. The Company operates in one reportable segment, which comprises the development and sale of Creative medical devices for therapeutic care. The company's solutions includes Multi-Modality Oxygen Therapy, Extremity Chamber, Multi-Patch, Negative Pressure Wound Therapy.
21GF Score

Get the complete analysis for LSE:AOTI

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.62
Price